Black Rock Inc. Coherus Bio Sciences, Inc. Call Options Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CHRS
# of Institutions
119Shares Held
58.2MCall Options Held
89.3KPut Options Held
31K-
Vanguard Group Inc Valley Forge, PA10.6MShares$14.5 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA5.1MShares$6.98 Million0.22% of portfolio
-
Kohlberg Kravis Roberts & Co. L.P. New York, NY3.04MShares$4.16 Million0.09% of portfolio
-
Geode Capital Management, LLC Boston, MA2.68MShares$3.67 Million0.0% of portfolio
-
Cm Management, LLC2.25MShares$3.08 Million1.68% of portfolio
About Coherus BioSciences, Inc.
- Ticker CHRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,724,600
- Market Cap $106M
- Description
- Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...